A project led by Department of Experimental Psychology's Alex Hendry, working with Oxford Brookes, has engaged with parents and early years practitioners in a bid to help families spend more time playing with their children.
It may not be quite time to throw out the psychiatrist\u2019s couch, but Oxford Professor of Psychiatry Andrea Cipriani is hoping his research might transform the traditional approach to mental health treatment.
In his inaugural article in the Proceedings of the National Academy of Sciences as an NAS member (elected 2021), Prof Mike Dustin and his research team in Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences have explained how messages are passed across the immunological synapse. The research could have implications for future vaccine development and immunotherapy treatments.
A local collaboration teaming researchers from the University of Oxford and Oxford Brookes University with the Urban Music Foundation finished on a high note with an immersive sound and art installation at Oxford\u2019s Old Fire Station.
The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their \u201csmart\u201d bioelectronic implants.
A new study led by researchers at the University of Oxford\u2019s Department of Computer Science has found that, between 2021 and 2022, COVID-19 was a leading cause of death in children and young people in the United States, ranking eighth overall. The results demonstrate that pharmaceutical and public health interventions should continue to be applied to limit the spread of the coronavirus and protect again severe disease in this age group.
Researchers in the Department of Physiology, Anatomy and Genetics (DPAG) have developed a blood test that measures stress hormone levels after heart attacks. The test \u2013 costing just \u00a310 \u2013 could ensure patients receive timely life-saving treatment.
A survey of over 2000 British adults has found that public trust in science, particularly genetics, increased significantly during the pandemic. However, those with extremely negative attitudes towards science tend to have high self-belief in their own understanding despite low textbook knowledge.
Hip fracture patients in Low- and Middle-Income Countries (LMIC) in Asia are set to benefit from a new study that aims to bring best practice programmes to improve quality of life for patients and reduce healthcare costs.
Congratulations to Professor Gero Miesenb\u00f6ck, Department of Physiology, Anatomy and Genetics (DPAG), who has been awarded the 2023 Japan Prize in the field of Life Sciences, together with Professor Karl Deisseroth, for pioneering work in the field of optogenetics.
Cancer Research UK and the National Institute for Health and Care Research are investing over \u00a33 million across the next five years into The University of Oxford\u2019s Experimental Cancer Medicine Centre (ECMC). The investment will enable Oxford to expand its portfolio of precision prevention and early detection cancer trials.
The Department of Experimental Psychology are delighted to announce that Daniel Freeman has been appointed as their new Professor of Psychology, joining from the Department of Psychiatry.
It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.
The global network led by the Oxford Maternal and Perinatal Health Institute (OMPHI) at the University of Oxford has today published, in The Lancet, the results of the \u20182022 INTERCOVID Study\u2019 conducted in 41 hospitals across 18 countries.
A consortium led by Matthew Wood, Professor of Neuroscience in the Department of Paediatrics and Director of the Oxford-Harrington Rare Disease Centre, has been awarded \u00a38m of funding from UKRI, LifeArc and the Nucleic Acid Therapy Accelerator (NATA) via the Nucleic Acid Therapies (NAT) Delivery Research Challenge.
Three University of Oxford spinouts have raised significant investment to scale their companies in vehicle automation, quantum computing and medical imaging respectively.
Researchers from the University of Oxford released findings from a clinical trial investigating the effectiveness of the antiviral treatment molnupiravir against COVID-19 \u2013 the first treatment tested in the ongoing PANORAMIC trial. In their paper published in The Lancet, they reported that molnupiravir did not reduce hospitalisations or deaths among higher risk, vaccinated adults with COVID-19 in the community.
![\"Children](\"https://www.medsci.ox.ac.uk/news/community-play-packs-inspire-families-to-be-more-playful-at-home/responsive_image?ratio=r16x9&scale=w760\")
\n \n \n\n\n